Search for: "Teva Pharmaceuticals USA, Inc." Results 301 - 320 of 489
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc. (Fed Cir. 2013)
16 Sep 2013, 9:59 pm by Patent Docs
Teva Pharmaceuticals USA. [read post]
Patent Docs - http://www.patentdocs.org/
Judge Rader’s Obviousness Tutorial: Including the Conclusion that Older Prior Art is Less Credible and a Restatement that Objective Indicia of Nonobviousness Play a Critical Role
28 Aug 2013, 10:31 am by Dennis Crouch
By Dennis Crouch Leo Pharmaceutical Products, Ltd. v. [read post]
Patently-O - http://patentlyo.com/patent
Leo Pharma v. Rea: Fleshing Out “Obvious to Try” Combinations
26 Aug 2013, 7:15 pm
USA, Inc., 367 F.3d 1381, 1385 (Fed. [read post]
Journal of the Patent and Trademark Office Society - http://jptos.org
Court Report
18 Aug 2013, 8:54 pm by Patent Docs
Teva Biopharmaceuticals USA, Inc. et al. 2:13-cv-04911; filed August 12, 2013 in the District Court of New Jersey • Plaintiffs: Amgen Inc.; Amgen Manufacturing, Limited • Defendants: Teva Biopharmaceuticals USA, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
Patent Docs - http://www.patentdocs.org/
Federal Circuit Finds “Molecular Weight” To Be Insolubly Ambiguous
7 Aug 2013, 11:00 pm by Daniel R. Shelton
In Teva Pharmaceuticals USA, Inc. v. [read post]
PharmaPatents - http://www.pharmapatentsblog.com
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (Fed. Cir. 2013)
29 Jul 2013, 9:26 pm by Patent Docs
This principle of patent law was reaffirmed by the Federal Circuit last week in Teva Pharmaceuticals USA, Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Revisiting Publisher (Non)Liability
18 Jul 2013, 10:45 am by Bexis
Teva Pharmaceuticals, 726 F. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Court Report - Part I
14 Jul 2013, 9:23 pm by Patent Docs
• Defendants: Teva Pharmaceuticals USA Inc.; Teva Pharmaceutical Industries Ltd. [read post]
Patent Docs - http://www.patentdocs.org/
USPTO Grants Pfizer Reissue Patent for Celebrex®
1 Apr 2013, 8:29 am by Gene Quinn
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu
Court Report
17 Mar 2013, 9:39 pm by Patent Docs
• Defendants: Teva Pharmaceutical Industries, Ltd.; Teva Pharmaceuticals USA, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Court Report
10 Mar 2013, 9:59 pm by Patent Docs
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
Patent Docs - http://www.patentdocs.org/
Copying in ANDA Case Not Compelling Evidence of Nonobviousness
20 Feb 2013, 7:37 am by Docket Navigator
Teva Pharmaceuticals USA Inc., et. al., 1-10-cv-00805 (DED February 11, 2013, Order) (Burke, M.J.). [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Judge Burke holds plaintiff’s patent invalid as obvious, but denies defendant’s inequitable conduct claim in ANDA litigation
15 Feb 2013, 9:29 am by Gregory J. Brodzik
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Federal Circuit’s Criticism of Expert Provides no Basis for Late Substitution
8 Feb 2013, 11:04 am by Docket Navigator
Teva Pharmaceuticals USA, Inc., et. al., 1-10-cv-01796 (NYSD February 6, 2013, Order) (Sullivan, J.). [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Spherical Error Revisited
1 Feb 2013, 9:42 am by Bexis
Wyeth Pharmaceuticals, Inc. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Are generics bioequivalent?
21 Jan 2013, 7:27 am by Lawrence B. Ebert
Food and Drug Administration said Wednesday the product, Budeprion XL 300 milligrams, which is manufactured by Impax Laboratories Inc. and marketed by Teva Pharmaceuticals USA Inc., "is not therapeutically equivalent to Wellbutrin XL 300 mg" or the extended-release version of Wellbutrin.In a post titled A Drug Recall That Should Frighten Us All About The FDA The People’s Pharmacy, a well-known syndicated radio and newspaper columnist husband and… [read post]
IPBiz - http://ipbiz.blogspot.com/
Weeks Reasoning – No Sweet Home In Alabama For Research Pharma
18 Jan 2013, 2:06 pm by Bexis
  The Decherts are too involved in this litigation to comment publicly.There aren’t many research-oriented pharmaceutical companies based in Alabama, and after last week’s execrable decision in Wyeth, Inc. v. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Anti-Bartlett Arguments
27 Dec 2012, 3:47 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2012 WL 1866839, at *5 (W.D. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
“Product Hopping” Antitrust Lawsuit Takes on a Heightened Profile with Proposed FTC Amicus Brief
25 Nov 2012, 5:42 pm by FDABlog HPM
USA, Inc., 432 F. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Judge Andrews Issues Claim Construction Opinion Related to Anti-HIV Pharmaceuticals
21 Nov 2012, 11:32 am by Robert Vrana
Teva Pharmaceuticals USA, Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/